webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Fmoc-L-Dap(Poc)-OH

  CAS No.: 2250437-44-4   Cat No.: BADC-01816 4.5  

Fmoc-L-Dap(Poc)-OH is a protected amino acid ADC linker intermediate designed for precise antibody conjugation, improving antibody-drug conjugate synthesis efficiency and targeted drug delivery.

Fmoc-L-Dap(Poc)-OH

Structure of 2250437-44-4

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C22H20N2O6
Molecular Weight
408.40

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
(S)-1-(9H-Fluoren-9-yl)-3,8-dioxo-2,9-dioxa-4,7-diazadodec-11-yne-5-carboxylic acid
IUPAC Name
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-(prop-2-ynoxycarbonylamino)propanoic acid
Canonical SMILES
C#CCOC(=O)NCC(C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13
InChI
InChI=1S/C22H20N2O6/c1-2-11-29-21(27)23-12-19(20(25)26)24-22(28)30-13-18-16-9-5-3-7-14(16)15-8-4-6-10-17(15)18/h1,3-10,18-19H,11-13H2,(H,23,27)(H,24,28)(H,25,26)/t19-/m0/s1
InChIKey
SUBBTJIFFMPNNY-IBGZPJMESA-N

Fmoc-L-Dap(Poc)-OH, a protected amino acid derivative widely utilized in peptide synthesis, plays a pivotal role in various applications. Here are four key applications of Fmoc-L-Dap(Poc)-OH:

Peptide Synthesis: Acting as a cornerstone in solid-phase peptide synthesis, Fmoc-L-Dap(Poc)-OH enables the incorporation of diaminopropionic acid residues into peptide chains. This compound facilitates selective deprotection steps, allowing for the construction of intricate peptide sequences with utmost purity and specificity. Its utilization ensures the production of functional peptides crucial for both research endeavors and therapeutic interventions.

Drug Design: Positioned at the forefront of pharmaceutical innovation, Fmoc-L-Dap(Poc)-OH facilitates the development of peptide-based drugs by enabling the strategic introduction of functional groups at specific locations along the peptide chain. This adaptability enhances the stability, bioavailability, and efficacy of peptide drugs. Researchers harness this derivative to engineer peptides tailored to target distinct receptors or pathways.

Bioconjugation: Embraced in the realm of bioconjugation, Fmoc-L-Dap(Poc)-OH serves as a linchpin in linking peptides to diverse biomolecules such as proteins, nucleic acids, or polymers. The protected amine group offers a platform for selective modification and attachment, culminating in the creation of bioconjugates essential for designing diagnostic tools, vaccines, and targeted delivery systems.

Structural Studies: Introducing Fmoc-L-Dap(Poc)-OH into peptide sequences unlocks opportunities for delving into the structural and functional aspects of peptides. Researchers leverage this derivative to explore how specific residues influence peptide folding, stability, and interactions with other molecules, shedding light on peptide dynamics.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: N3-D-Dab(Boc)-OH | Boc-L-Cys(Propargyl)-OH | Mal-AMCHC-N-Propargylamide | Sulfo DBCO-TFP Ester | (2S,3R)-H-Abu(3-N3)-OH hydrochloride | Me-Tet-PEG2-COOH | H-L-Lys(4-N3-Z)-OH HCl | (2R,4R)-H-D-Pro(4-N3)-OH hydrochloride | NH-bis(C1-Boc) | Disuccinimidyl glutarate | Fmoc-L-Dap(Poc)-OH
Send Inquiry
Verification code
Inquiry Basket